Fundies.
English

Insider transactions

EDGAR

CURTISS-WRIGHT CORPORATION

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-15.

Open-market purchases (code P)
1 transactions, 209.3801 shares
Sum of shares × price per share: 148,999.066762
Open-market sales (code S)
28 transactions, 34,729 shares
Sum of shares × price per share: 22,969,433.83

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–50 of 78

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-08-28 Filed 2026-08-31Wyche Larry D Director
S

Open market or private sale of non-derivative or derivative security

Common Stock		Disposed (D)100596.74
59,674

Derived: shares × price per share. Exact value 59674.00.

1,414Direct (D) No
F1
  • F1 Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell shares provided the Reporting Person is and remains in compliance with the share ownership guidelines.
Open filing 0001628280-26-059568 Read from the filing’s XML Dispute this row
2026-08-27 Filed 2026-08-27Watts John C Officer: EVP Chief Growth Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock		Disposed (D)1,035619.46
641,141.1

Derived: shares × price per share. Exact value 641141.10.

2,736Direct (D) No
F1
  • F1 The reporting person contributed Issuer common stock (Common Stock) to an exchange fund in exchange for shares of the exchange fund. For purposes of determining the number of shares of the exchange fund issuable pursuant to such exchange, the Common Stock was valued at $619.46 per share, which was the closing price of the Common Stock on the New York Stock Exchange on August 26, 2026. The transaction with the exchange fund closed on August 27, 2025.
Open filing 0001628280-26-059267 Read from the filing’s XML Dispute this row
2026-08-10 Filed 2026-08-10Lyash Jeffrey J. Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock		Acquired (A)209.3801711.62
148,999.066762

Derived: shares × price per share. Exact value 148999.066762.

257.3801Direct (D) No— Open filing 0001628280-26-055200 Read from the filing’s XML Dispute this row
2026-07-06 Filed 2026-07-06Watts John C Officer: EVP Chief Growth Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock		Acquired (A)9634.88
5,713.92

Derived: shares × price per share. Exact value 5713.92.

3,771Direct (D) No
F1, F2
  • F1 Shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan (ESPP), under which the Reporting Person agrees to payroll deductions prior to the commencement of a six-month offering period whereby the payroll deductions are accumulated for the purchase of shares at the end of the offering period. This transaction is exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  • F2 In accordance with the terms of the ESPP, the purchase price is calculated by giving a 15% discount on the average selling price of the Issuer's common stock price on June 30, 2026, the last day of the offering period.
Open filing 0001628280-26-047237 Read from the filing’s XML Dispute this row
2026-07-06 Filed 2026-07-06Bamford Lynn M Director · Officer: Chair and CEO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock		Acquired (A)17634.88
10,792.96

Derived: shares × price per share. Exact value 10792.96.

45,651Direct (D) No
F1, F2
  • F1 Shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan (ESPP), under which the Reporting Person agrees to payroll deductions prior to the commencement of a six-month offering period whereby the payroll deductions are accumulated for the purchase of shares at the end of the offering period. This transaction is exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  • F2 In accordance with the terms of the ESPP, the purchase price is calculated by giving a 15% discount on the average selling price of the Issuer's common stock price on June 30, 2026, the last day of the offering period.
Open filing 0001628280-26-047231 Read from the filing’s XML Dispute this row
2026-07-06 Filed 2026-07-06Rayment Kevin Officer: Executive VP and COO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock		Acquired (A)26634.88
16,506.88

Derived: shares × price per share. Exact value 16506.88.

31,519Direct (D) No
F1, F2
  • F1 Shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan (ESPP), under which the Reporting Person agrees to payroll deductions prior to the commencement of a six-month offering period whereby the payroll deductions are accumulated for the purchase of shares at the end of the offering period. This transaction is exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  • F2 In accordance with the terms of the ESPP, the purchase price is calculated by giving a 15% discount on the average selling price of the Issuer's common stock price on June 30, 2026, the last day of the offering period.
Open filing 0001628280-26-047236 Read from the filing’s XML Dispute this row
2026-07-06 Filed 2026-07-06McDonald George P. Officer: Executive VP and Corporate Sec
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock		Acquired (A)25634.88
15,872

Derived: shares × price per share. Exact value 15872.00.

4,235Direct (D) No
F1, F2
  • F1 Shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan (ESPP), under which the Reporting Person agrees to payroll deductions prior to the commencement of a six-month offering period whereby the payroll deductions are accumulated for the purchase of shares at the end of the offering period. This transaction is exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  • F2 In accordance with the terms of the ESPP, the purchase price is calculated by giving a 15% discount on the average selling price of the Issuer's common stock price on June 30, 2026, the last day of the offering period.
Open filing 0001628280-26-047242 Read from the filing’s XML Dispute this row
2026-07-06 Filed 2026-07-06Farkas K Christopher Officer: Executive VP and CFO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock		Acquired (A)21634.88
13,332.48

Derived: shares × price per share. Exact value 13332.48.

4,274Direct (D) No
F1, F2
  • F1 Shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan (ESPP), under which the Reporting Person agrees to payroll deductions prior to the commencement of a six-month offering period whereby the payroll deductions are accumulated for the purchase of shares at the end of the offering period. This transaction is exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  • F2 In accordance with the terms of the ESPP, the purchase price is calculated by giving a 15% discount on the average selling price of the Issuer's common stock price on June 30, 2026, the last day of the offering period.
Open filing 0001628280-26-047233 Read from the filing’s XML Dispute this row
2026-06-15 Filed 2026-06-15Watts John C Officer: EVP Chief Growth Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock		Disposed (D)200770.56
154,112

Derived: shares × price per share. Exact value 154112.00.

3,762Direct (D) Yes
F1, F2
  • F1 Sale was made in accordance with a Rule 10b5-1 trading plan adopted by the Reporting Person on February 25, 2026 and maintained by the Reporting Person's financial advisor.
  • F2 Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell shares provided the Reporting Person is and remains in compliance with the share ownership guidelines.
Open filing 0001628280-26-043157 Read from the filing’s XML Dispute this row
2026-06-12 Filed 2026-06-15Bamford Lynn M Director · Officer: Chair and CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock		Disposed (D)2,500758.20
1,895,500

Derived: shares × price per share. Exact value 1895500.00.

45,634Direct (D) Yes
F1, F2, F3
  • F1 Sale was made in accordance with a 10b5-1 plan adopted by the Reporting Person on March 10, 2026 and maintained by the Reporting Person's financial advisor.
  • F2 Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell shares provided the Reporting Person is and remains in compliance with the share ownership guidelines.
  • F3 The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $754.05 to $766.75, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.
Open filing 0001628280-26-043153 Read from the filing’s XML Dispute this row
2026-06-09 Filed 2026-06-10Ogilby Gary A Officer: Senior VP Corp Controller
S

Open market or private sale of non-derivative or derivative security

Common Stock		Disposed (D)399721.95
288,058.05

Derived: shares × price per share. Exact value 288058.05.

2,172Direct (D) Yes
F1, F2, F3
  • F1 Sale was made in accordance with a 10b5-1 plan adopted by the Reporting Person on March 10, 2026 and maintained by the Reporting Person's financial advisor.
  • F2 Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell shares provided the Reporting Person is and remains in compliance with the share ownership guidelines.
  • F3 The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $705.34 to $736.99, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.
Open filing 0001628280-26-042196 Read from the filing’s XML Dispute this row
2026-06-09 Filed 2026-06-10Bamford Lynn M Director · Officer: Chair and CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock		Disposed (D)2,500721.72
1,804,300

Derived: shares × price per share. Exact value 1804300.00.

48,134Direct (D) Yes
F1, F2, F3
  • F1 Sale was made in accordance with a 10b5-1 plan adopted by the Reporting Person on March 10, 2026 and maintained by the Reporting Person's financial advisor
  • F2 Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell shares provided the Reporting Person is and remains in compliance with the share ownership guidelines.
  • F3 The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $703.54 to $739.63, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.
Open filing 0001628280-26-042193 Read from the filing’s XML Dispute this row
2026-06-01 Filed 2026-06-02Wallace Peter C Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock		Acquired (A)221719.99
159,117.79

Derived: shares × price per share. Exact value 159117.79.

6,209Direct (D) No
F1, F2, F3
  • F1 Shares were acquired through the Corporation's 2024 Omnibus Incentive Plan whereby non-employee directors may elect to defer their compensation, including their annual restricted stock award, and/or receive their annual retainer and meeting fees in the form of stock at a later date.
  • F2 Reflects the annual restricted stock award that was earned in 2021, but receipt was deferred to June 1, 2025. Number of shares acquired is calculated based on the value of the award ($125,000) divided by the closing price of $115.24 for the Issuer's common stock as reported by the New York Stock Exchange on February 16, 2021, the date the Board initially approved the award. The number of shares is rounded up to the nearest whole share and includes dividend credits earned on outstanding award. This amount reflects 20% of the Reporting Person's restricted stock award as the reporting person elected to receive the restricted stock in five equal installments beginning June 1, 2025.
  • F3 Price is based on the closing market price for the Issuer's securities on the New York Stock Exchange as of June 1, 2026. The date recipient elected to receive his shares.
Open filing 0001628280-26-039795 Read from the filing’s XML Dispute this row
2026-05-29 Filed 2026-06-02MINOR GLENDA J Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock		Acquired (A)20747.61
14,952.2

Derived: shares × price per share. Exact value 14952.20.

2,491.01Direct (D) No
F1, F2, F3
  • F1 Shares were acquired through the Corporation's 2024 Omnibus Incentive Plan whereby non-employee directors may elect to receive their annual retainer, committee chair, and meeting fees in the form of stock.
  • F2 Number of shares is calculated by taking the amount of the Reporting Person's earned retainer and dividing that amount by the closing price of the Issuer's common stock on the date such retainer was earned.
  • F3 Price is based on the closing market price for the Issuer's securities on the New York Stock Exchange as of May 29, 2026. The date recipient elected to receive her shares.
Open filing 0001628280-26-039799 Read from the filing’s XML Dispute this row
2026-05-27 Filed 2026-05-27Watts John C Officer: EVP Chief Growth Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock		Disposed (D)220752.91
165,640.2

Derived: shares × price per share. Exact value 165640.20.

3,962Direct (D) Yes
F1, F2
  • F1 Sale was made in accordance with a Rule 10b5-1 trading plan adopted by the Reporting Person on February 25, 2026 and maintained by the Reporting Person's financial advisor.
  • F2 Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell shares provided the Reporting Person is and remains in compliance with the share ownership guidelines.
Open filing 0001628280-26-038454 Read from the filing’s XML Dispute this row
2026-05-12 Filed 2026-05-14MINOR GLENDA J Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock		Acquired (A)221735.34
162,510.14

Derived: shares × price per share. Exact value 162510.14.

2,471.01Direct (D) No
F1, F2, F3
  • F1 Shares were acquired through the Corporation's 2024 Omnibus Incentive Plan whereby non-employee directors may elect to defer receipt of their annual restricted stock award to a later date.
  • F2 Number of shares acquired is calculated based on the value of the award ($125,000) divided by the closing price of $115.24 for the Issuer's common stock as reported by the New York Stock Exchange on February 16, 2021, the date the Board initially approved the award. The number of shares is rounded up to the nearest whole share and includes dividend credits earned on outstanding award. This amount reflects 20% of the reporting person's restricted stock award as the reporting person elected to receive the restricted stock award in five equal annual installments beginning May 12, 2024.
  • F3 Price is based on the closing market price for the Issuer's securities on the New York Stock Exchange as of May 12, 2026. The date reporting person elected to receive her shares.
Open filing 0001628280-26-035111 Read from the filing’s XML Dispute this row
2026-05-07 Filed 2026-05-11Lyash Jeffrey J. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock		Acquired (A)480—48Direct (D) No
F1, F2
  • F1 Shares were issued pursuant to the Company's 2024 Omnibus Incentive Plan in which newly elected non-employee directors receive an initial grant of restricted stock in the amount of $35,000 for service on the board. The restrictions on these shares lapse upon the shorter of (a) five years from the date of grant or (b) until such time as the service of the recipient as a non-employee director of the Company shall have ended by reason of his or her (i) death or disability or (ii) failure to be reelected.
  • F2 The number of shares calculated is based on the value of the award ($35,000.00) divided by the closing price of $724.43 for Issuer's common stock as reported by the New York Stock Exchange on May 7, 2026, the date the reporting person was elected to the Board of Directors.
Open filing 0001628280-26-033163 Read from the filing’s XML Dispute this row
2026-03-18 Filed 2026-03-19Farkas K Christopher Officer: Executive VP and CFO
S

Open market or private sale of non-derivative or derivative security

Common Stock		Disposed (D)1,265689.69
872,457.85

Derived: shares × price per share. Exact value 872457.85.

4,253Direct (D) Yes
F1, F2
  • F1 Sale was made in accordance with a Rule 10b5-1 trading plan adopted by the Reporting Person on November 10, 2025 and maintained by the Reporting Person's financial advisor.
  • F2 The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $681.18 to $699.31, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.
Open filing 0001628280-26-019786 Read from the filing’s XML Dispute this row
2026-03-18 Filed 2026-03-19Ogilby Gary A Officer: Senior VP Corp Controller
S

Open market or private sale of non-derivative or derivative security

Common Stock		Disposed (D)252689.14
173,663.28

Derived: shares × price per share. Exact value 173663.28.

2,571Direct (D) Yes
F1, F2
  • F1 Sale was made in accordance with a Rule 10b5-1 trading plan adopted by the Reporting Person on September 11, 2025 and maintained by the Reporting Person's financial advisor.
  • F2 The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $682.74 to $698.09, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.
Open filing 0001628280-26-019788 Read from the filing’s XML Dispute this row
2026-03-17 Filed 2026-03-18Watts John C Officer: EVP Chief Growth Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock		Disposed (D)220678.11
149,184.2

Derived: shares × price per share. Exact value 149184.20.

4,182Direct (D) No
F3, F4
  • F3 Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell a portion of the vesting award to cover any tax obligations associated with the vesting of the award. The Reporting Person is and remains in compliance with the share ownership guidelines.
  • F4 The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $671.53 to $681.02, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.
Open filing 0001628280-26-019408 Read from the filing’s XML Dispute this row
2026-03-17 Filed 2026-03-18Rayment Kevin Officer: Executive VP and COO
S

Open market or private sale of non-derivative or derivative security

Common Stock		Disposed (D)907677.38
614,383.66

Derived: shares × price per share. Exact value 614383.66.

31,493Direct (D) No
F3, F4
  • F3 Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell a portion of the vesting award to cover any tax obligations associated with the vesting of the award. The Reporting Person is and remains in compliance with the share ownership guidelines.
  • F4 The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $671.52 to $681, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.
Open filing 0001628280-26-019397 Read from the filing’s XML Dispute this row
2026-03-17 Filed 2026-03-18Farkas K Christopher Officer: Executive VP and CFO
S

Open market or private sale of non-derivative or derivative security

Common Stock		Disposed (D)918677.46
621,908.28

Derived: shares × price per share. Exact value 621908.28.

5,518Direct (D) No
F3, F4
  • F3 Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell a portion of the vesting award to cover any tax obligations associated with the vesting of the award. The Reporting Person is and remains in compliance with the share ownership guidelines.
  • F4 The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $669.72 to $681.43, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.
Open filing 0001628280-26-019395 Read from the filing’s XML Dispute this row
2026-03-17 Filed 2026-03-18McDonald George P. Officer: Executive VP and Corporate Sec
S

Open market or private sale of non-derivative or derivative security

Common Stock		Disposed (D)151678.07
102,388.57

Derived: shares × price per share. Exact value 102388.57.

4,210Direct (D) No
F3, F4
  • F3 Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell a portion of the vesting award to cover any tax obligations associated with the vesting of the award. The Reporting Person is and remains in compliance with the share ownership guidelines.
  • F4 The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $671.25 to $681.02, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.
Open filing 0001628280-26-019400 Read from the filing’s XML Dispute this row
2026-03-17 Filed 2026-03-18Ogilby Gary A Officer: Senior VP Corp Controller
S

Open market or private sale of non-derivative or derivative security

Common Stock		Disposed (D)148678.30
100,388.4

Derived: shares × price per share. Exact value 100388.40.

2,823Direct (D) No
F3, F4
  • F3 Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell a portion of the vesting award to cover any tax obligations associated with the vesting of the award. The Reporting Person is and remains in compliance with the share ownership guidelines.
  • F4 The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $671.53 to $681.02, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.
Open filing 0001628280-26-019402 Read from the filing’s XML Dispute this row
2026-03-17 Filed 2026-03-18Bamford Lynn M Director · Officer: Chair and CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock		Disposed (D)3,225676.70
2,182,357.5

Derived: shares × price per share. Exact value 2182357.50.

50,634Direct (D) No
F3, F4
  • F3 Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell a portion of the vesting award to cover any tax obligations associated with the vesting of the award. The Reporting Person is and remains in compliance with the share ownership guidelines.
  • F4 The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $669.05 to $681, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.
Open filing 0001628280-26-019388 Read from the filing’s XML Dispute this row
2026-03-17 Filed 2026-03-18Freda Robert F Officer: Senior VP Treasurer
S

Open market or private sale of non-derivative or derivative security

Common Stock		Disposed (D)140678.61
95,005.4

Derived: shares × price per share. Exact value 95005.40.

5,343Direct (D) No
F3, F4
  • F3 Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell a portion of the vesting award to cover any tax obligations associated with the vesting of the award. The Reporting Person is and remains in compliance with the share ownership guidelines.
  • F4 The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $671.23 to $681.66, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.
Open filing 0001628280-26-019405 Read from the filing’s XML Dispute this row
2026-03-16 Filed 2026-03-18Watts John C Officer: EVP Chief Growth Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock		Acquired (A)5120—4,402Direct (D) No
F1, F2
  • F1 These shares were acquired through a restricted stock unit (RSU) grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.
  • F2 No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
Open filing 0001628280-26-019408 Read from the filing’s XML Dispute this row
2026-03-16 Filed 2026-03-18Watts John C Officer: EVP Chief Growth Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Unit — underlying Common Stock (512) — exercise price 0		Disposed (D)5120—895Direct (D) No
F2, F1, F5
  • F2 No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
  • F1 These shares were acquired through a restricted stock unit (RSU) grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.
  • F5 Share total includes dividend credits earned on prior outstanding grants.
Open filing 0001628280-26-019408 Read from the filing’s XML Dispute this row
2026-03-16 Filed 2026-03-18Rayment Kevin Officer: Executive VP and COO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock		Acquired (A)2,5040—32,400Direct (D) No
F1, F2
  • F1 These shares were acquired through a restricted stock unit (RSU) grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.
  • F2 No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
Open filing 0001628280-26-019397 Read from the filing’s XML Dispute this row
2026-03-16 Filed 2026-03-18Rayment Kevin Officer: Executive VP and COO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Unit — underlying Common Stock (2,504) — exercise price 0		Disposed (D)2,5040—3,928Direct (D) No
F2, F1, F5
  • F2 No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
  • F1 These shares were acquired through a restricted stock unit (RSU) grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.
  • F5 Share total includes dividend credits earned on prior outstanding grants.
Open filing 0001628280-26-019397 Read from the filing’s XML Dispute this row
2026-03-16 Filed 2026-03-18Farkas K Christopher Officer: Executive VP and CFO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock		Acquired (A)2,1830—6,436Direct (D) No
F1, F2
  • F1 These shares were acquired through a restricted stock unit (RSU) grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.
  • F2 No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
Open filing 0001628280-26-019395 Read from the filing’s XML Dispute this row
2026-03-16 Filed 2026-03-18Farkas K Christopher Officer: Executive VP and CFO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Unit — underlying Common Stock (2,183) — exercise price 0		Disposed (D)2,1830—9,366Direct (D) No
F2, F1, F5
  • F2 No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
  • F1 These shares were acquired through a restricted stock unit (RSU) grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.
  • F5 Share total includes dividend credits earned on prior outstanding grants.
Open filing 0001628280-26-019395 Read from the filing’s XML Dispute this row
2026-03-16 Filed 2026-03-18McDonald George P. Officer: Executive VP and Corporate Sec
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock		Acquired (A)3500—4,361Direct (D) No
F1, F2
  • F1 These shares were acquired through a restricted stock unit (RSU) grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.
  • F2 No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
Open filing 0001628280-26-019400 Read from the filing’s XML Dispute this row
2026-03-16 Filed 2026-03-18McDonald George P. Officer: Executive VP and Corporate Sec
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Unit — underlying Common Stock (350) — exercise price 0		Disposed (D)3500—1,112Direct (D) No
F2, F1, F5
  • F2 No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
  • F1 These shares were acquired through a restricted stock unit (RSU) grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.
  • F5 Share total includes dividend credits earned on prior outstanding grants.
Open filing 0001628280-26-019400 Read from the filing’s XML Dispute this row
2026-03-16 Filed 2026-03-18Ogilby Gary A Officer: Senior VP Corp Controller
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock		Acquired (A)4000—2,971Direct (D) No
F1, F2
  • F1 These shares were acquired through a restricted stock unit (RSU) grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.
  • F2 No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
Open filing 0001628280-26-019402 Read from the filing’s XML Dispute this row
2026-03-16 Filed 2026-03-18Ogilby Gary A Officer: Senior VP Corp Controller
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Unit — underlying Common Stock (400) — exercise price 0		Disposed (D)4000—4,420Direct (D) No
F2, F1, F5
  • F2 No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
  • F1 These shares were acquired through a restricted stock unit (RSU) grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.
  • F5 Share total includes dividend credits earned on prior outstanding grants.
Open filing 0001628280-26-019402 Read from the filing’s XML Dispute this row
2026-03-16 Filed 2026-03-18Bamford Lynn M Director · Officer: Chair and CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock		Acquired (A)7,6670—53,859Direct (D) No
F1, F2
  • F1 These shares were acquired through a restricted stock unit (RSU) grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.
  • F2 No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
Open filing 0001628280-26-019388 Read from the filing’s XML Dispute this row
2026-03-16 Filed 2026-03-18Bamford Lynn M Director · Officer: Chair and CEO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Unit — underlying Common Stock (7,667) — exercise price 0		Disposed (D)7,6670—14,614Direct (D) No
F2, F1, F5
  • F2 No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
  • F1 These shares were acquired through a restricted stock unit (RSU) grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.
  • F5 Share total includes dividend credits earned on prior outstanding grants.
Open filing 0001628280-26-019388 Read from the filing’s XML Dispute this row
2026-03-16 Filed 2026-03-18Freda Robert F Officer: Senior VP Treasurer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock		Acquired (A)2960—5,483Direct (D) No
F1, F2
  • F1 These shares were acquired through a restricted stock unit (RSU) grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.
  • F2 No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
Open filing 0001628280-26-019405 Read from the filing’s XML Dispute this row
2026-03-16 Filed 2026-03-18Freda Robert F Officer: Senior VP Treasurer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Restricted Stock Unit — underlying Common Stock (296) — exercise price 0		Disposed (D)2960—4,269Direct (D) No
F2, F1, F5
  • F2 No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
  • F1 These shares were acquired through a restricted stock unit (RSU) grant under the Company's 2014 Omnibus Incentive Plan on March 16, 2023. The RSUs cliff vested in Issuer common stock after a three-year vesting period from the date of grant.
  • F5 Share total includes dividend credits earned on prior outstanding grants.
Open filing 0001628280-26-019405 Read from the filing’s XML Dispute this row
2026-03-09 Filed 2026-03-10McDonald George P. Officer: Executive VP and Corporate Sec
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Unit — underlying Common Stock (304) — exercise price 0		Acquired (A)3040—1,462Direct (D) No
F2, F3, F4
  • F2 This is a time-based restricted stock unit (RSU) grant under the Company's 2024 Omnibus Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs will cliff vest after a three-year vesting period from the date of grant, which was March 9, 2026.
  • F3 No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
  • F4 Share total includes dividend credits earned on prior outstanding grants.
Open filing 0001628280-26-016434 Read from the filing’s XML Dispute this row
2026-03-09 Filed 2026-03-10Rayment Kevin Officer: Executive VP and COO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Unit — underlying Common Stock (652) — exercise price 0		Acquired (A)6520—6,432Direct (D) No
F1, F2, F3
  • F1 This is a time-based restricted stock unit (RSU) grant under the Company's 2024 Omnibus Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs will cliff vest after a three-year vesting period from the date of grant, which was March 9, 2026.
  • F2 No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
  • F3 Share total includes dividend credits earned on prior outstanding grants.
Open filing 0001628280-26-016432 Read from the filing’s XML Dispute this row
2026-03-09 Filed 2026-03-10Farkas K Christopher Officer: Executive VP and CFO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Unit — underlying Common Stock (645) — exercise price 0		Acquired (A)6450—11,549Direct (D) No
F1, F2, F3
  • F1 This is a time-based restricted stock unit (RSU) grant under the Company's 2024 Omnibus Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs will cliff vest after a three-year vesting period from the date of grant, which was March 9, 2026.
  • F2 No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
  • F3 Share total includes dividend credits earned on prior outstanding grants.
Open filing 0001628280-26-016430 Read from the filing’s XML Dispute this row
2026-03-09 Filed 2026-03-10Bamford Lynn M Director · Officer: Chair and CEO
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Unit — underlying Common Stock (2,735) — exercise price 0		Acquired (A)2,7350—22,281Direct (D) No
F1, F2, F3
  • F1 This is a time-based restricted stock unit (RSU) grant under the Company's 2024 Omnibus Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs will cliff vest after a three-year vesting period from the date of grant, which was March 9, 2026.
  • F2 No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
  • F3 Share total includes dividend credits earned on prior outstanding grants.
Open filing 0001628280-26-016427 Read from the filing’s XML Dispute this row
2026-03-09 Filed 2026-03-10Watts John C Officer: EVP Chief Growth Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Unit — underlying Common Stock (183) — exercise price 0		Acquired (A)1830—1,407Direct (D) No
F1, F2, F3
  • F1 This is a time-based restricted stock unit (RSU) grant under the Company's 2024 Omnibus Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs will cliff vest after a three-year vesting period from the date of grant, which was March 9, 2026.
  • F2 No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
  • F3 Share total includes dividend credits earned on prior outstanding grants.
Open filing 0001628280-26-016444 Read from the filing’s XML Dispute this row
2026-03-09 Filed 2026-03-10Ogilby Gary A Officer: Senior VP Corp Controller
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Unit — underlying Common Stock (108) — exercise price 0		Acquired (A)1080—4,820Direct (D) No
F1, F2, F3
  • F1 This is a time-based restricted stock unit (RSU) grant under the Company's 2024 Omnibus Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs will cliff vest after a three-year vesting period from the date of grant, which was March 9, 2026.
  • F2 No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
  • F3 Share total includes dividend credits earned on prior outstanding grants.
Open filing 0001628280-26-016438 Read from the filing’s XML Dispute this row
2026-03-09 Filed 2026-03-10Freda Robert F Officer: Senior VP Treasurer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Restricted Stock Unit — underlying Common Stock (82) — exercise price 0		Acquired (A)820—4,565Direct (D) No
F1, F2, F3
  • F1 This is a time-based restricted stock unit (RSU) grant under the Company's 2024 Omnibus Incentive Plan. Each RSU represents a contingent right to receive one share of Issuer common stock. The RSUs will cliff vest after a three-year vesting period from the date of grant, which was March 9, 2026.
  • F2 No price on the date of issue. The restricted stock units were granted as an employee benefit transaction.
  • F3 Share total includes dividend credits earned on prior outstanding grants.
Open filing 0001628280-26-016440 Read from the filing’s XML Dispute this row
2026-02-18 Filed 2026-02-18Farkas K Christopher Officer: Executive VP and CFO
S

Open market or private sale of non-derivative or derivative security

Common Stock		Disposed (D)3,105694.51
2,156,453.55

Derived: shares × price per share. Exact value 2156453.55.

4,253Direct (D) Yes
F1, F2, F3
  • F1 Sale was made in accordance with a 10b5-1 plan adopted by the Reporting Person on November 10, 2025 and maintained by the Reporting Person's financial advisor.
  • F2 Shares were sold in compliance with the Company's share ownership guidelines whereby the Reporting Person may sell shares provided the Reporting Person is and remains in compliance with the share ownership guidelines.
  • F3 The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $687.55 to $703.23, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.
Open filing 0001628280-26-009091 Read from the filing’s XML Dispute this row
2026-02-05 Filed 2026-02-05Ogilby Gary A Officer: Senior VP Corp Controller
S

Open market or private sale of non-derivative or derivative security

Common Stock		Disposed (D)625624.32
390,200

Derived: shares × price per share. Exact value 390200.00.

2,571Direct (D) Yes
F5, F6
  • F5 Sale was made in accordance with a 10b5-1 plan adopted by the Reporting Person on September 11, 2025 and maintained by the Reporting Person's financial advisor.
  • F6 The price reported is the average selling price. The shares were sold in multiple transactions at prices ranging from $615.26 to $629.96, inclusive. The Reporting Person undertakes to provide the SEC, the issuer and any security holder full information regarding the number of shares sold at each separate price.
Open filing 0001628280-26-005806 Read from the filing’s XML Dispute this row
2026-02-04 Filed 2026-02-06Moraco Anthony J Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock		Acquired (A)256624.93
159,982.08

Derived: shares × price per share. Exact value 159982.08.

5,446Direct (D) No
F1, F2, F3
  • F1 Shares were issued pursuant to the Company's 2024 Omnibus Incentive Plan in which non-employee directors receive an annual grant of restricted stock for service on the board. The restrictions on these shares lapse upon the shorter of (a) one year from the date of grant or (b) until such time as the service of the recipient as a non-employee Director of the Company shall have ended by reason of his or her (i) death or disability or (ii) failure to be reelected.
  • F2 The number of shares is arrived by dividing the closing price of the Issuer's securities on February 4, 2026 into $160,000, the amount of the stock award granted to the Issuer's non-employee directors. The number of shares is rounded down to the nearest whole share.
  • F3 Price is based on the close price for the Registrant's common stock on February 4, 2026, the date the reporting person earned the annual award.
Open filing 0001628280-26-006021 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 7,211 filings read, the latest filed 2026-11-13. Prior quarter ending 2026-06-30: 9,150 filings read.

Showing 1–50 of 717

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
BlackRock, Inc. Partly reported under another manager4,605,797 SH2,504,724,358 dollarsHigher by 54,687 Prior quarter: 4,551,110Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
STATE STREET CORP Partly reported under another manager1,780,188 SH968,555,603 dollarsHigher by 77,770 Prior quarter: 1,702,418Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 1,656,167 SH900,656,738 dollarsLower by 12,845 Prior quarter: 1,669,012Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
VANGUARD PORTFOLIO MANAGEMENT LLC 1,618,282 SH880,054,117 dollarsLower by 31,190 Prior quarter: 1,649,472Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row
Invesco Ltd. Partly reported under another manager811,807 SH441,476,883 dollarsLower by 717,205 Prior quarter: 1,529,012Open filing 0000914208-26-000462 Filed 2026-11-12 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager691,661 SH375,057,520 dollarsLower by 49,998 Prior quarter: 741,659Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ Partly reported under another manager642,112 SH352,725,492 dollarsLower by 174,965 Prior quarter: 817,077Open filing 0000912938-26-001073 Filed 2026-11-12 Dispute this row
VAN ECK ASSOCIATES CORP Partly reported under another manager586,533 SH318,968,376 dollarsHigher by 935 Prior quarter: 585,598Open filing 0000869178-26-000119 Filed 2026-11-13 Dispute this row
PRIMECAP MANAGEMENT CO/CA/ 505,695 SH275,007,055 dollarsLower by 9,120 Prior quarter: 514,815Open filing 0000763212-26-000037 Filed 2026-11-12 Dispute this row
MORGAN STANLEY Partly reported under another manager504,275 SH274,236,801 dollarsHigher by 83,406 Prior quarter: 420,869Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
FRANKLIN TEMPLETON INC Partly reported under another manager501,330 SH226,666,333 dollarsLower by 26,904 Prior quarter: 528,234Open filing 0000038777-26-000291 Filed 2026-11-12 Dispute this row
FMR LLC Partly reported under another manager461,207 SH250,814,224 dollarsLower by 5,869 Prior quarter: 467,076Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row
Qube Research Technologies Ltd 396,079 SH215,395,682 dollarsHigher by 368,355 Prior quarter: 27,724Open filing 0001729829-26-000018 Filed 2026-11-13 Dispute this row
UBS Group AG Partly reported under another manager362,151 SH196,944,957 dollarsHigher by 153,691 Prior quarter: 208,460Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
Bank of New York Mellon Corp Partly reported under another manager345,722 SH188,010,424 dollarsLower by 11,196 Prior quarter: 356,918Open filing 0001390777-26-000121 Filed 2026-11-05 Dispute this row
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 305,868 SH166,337,136 dollarsLower by 11,438 Prior quarter: 317,306Open filing 0001644956-26-000031 Filed 2026-11-06 Dispute this row
Swedbank AB Partly reported under another manager299,483 SH162,864,846 dollarsHigher by 146,263 Prior quarter: 153,220Open filing 0000946431-26-000009 Filed 2026-10-27 Dispute this row
Allspring Global Investments Holdings, LLC Partly reported under another manager253,383 SH138,078,531 dollarsLower by 5,510 Prior quarter: 258,893Open filing 0001890906-26-000078 Filed 2026-11-04 Dispute this row
VANGUARD FIDUCIARY TRUST CO 236,715 SH128,730,351 dollarsHigher by 482 Prior quarter: 236,233Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
BNP PARIBAS ASSET MANAGEMENT Holding S.A. Partly reported under another manager236,531 SH128,630,288 dollarsHigher by 52,898 Prior quarter: 183,633Open filing 0001520354-26-000046 Filed 2026-11-13 Dispute this row
DIMENSIONAL FUND ADVISORS LP Partly reported under another manager220,464 SH119,873,914 dollarsHigher by 8,943 Prior quarter: 211,521Open filing 0000354204-26-001096 Filed 2026-11-04 Dispute this row
BLAIR WILLIAM CO/IL 220,416 SH119,866,418 dollarsHigher by 34,807 Prior quarter: 185,609Open filing 0001104659-26-124894 Filed 2026-11-10 Dispute this row
FIRST TRUST ADVISORS LP 207,138 SH112,645,503 dollarsHigher by 5,472 Prior quarter: 201,666Open filing 0001445546-26-008622 Filed 2026-11-12 Dispute this row
AMERICAN CENTURY COMPANIES INC Partly reported under another manager207,033 SH112,588,686 dollarsLower by 115,825 Prior quarter: 322,858Open filing 0000748054-26-000008 Filed 2026-11-12 Dispute this row
AXIOM INVESTORS LLC /DE 177,720 SH96,647,690 dollarsHigher by 22,812 Prior quarter: 154,908Open filing 0001109147-26-000007 Filed 2026-11-12 Dispute this row
Amundi Partly reported under another manager159,441 SH86,707,204 dollarsHigher by 4,773 Prior quarter: 154,668Open filing 0001172661-26-004884 Filed 2026-11-06 Dispute this row
JPMORGAN CHASE CO Partly reported under another manager155,993 SH84,381,966 dollarsHigher by 2,405 Prior quarter: 153,588Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row
CONGRESS ASSET MANAGEMENT CO 155,176 SH84,387,939 dollarsLower by 43,582 Prior quarter: 198,758Open filing 0000897378-26-000015 Filed 2026-10-06 Dispute this row
VICTORY CAPITAL MANAGEMENT INC 153,483 SH83,467,043 dollarsLower by 1,301 Prior quarter: 154,784Open filing 0001040188-26-000051 Filed 2026-11-10 Dispute this row
TimesSquare Capital Management, LLC 152,917 SH83,159,323 dollarsLower by 11,611 Prior quarter: 164,528Open filing 0001193125-26-444305 Filed 2026-11-03 Dispute this row
Cardano Risk Management B.V. 147,218 SH80,060 dollarsHigher by 4,282 Prior quarter: 142,936Open filing 0001619124-26-000009 Filed 2026-10-20 Dispute this row
Sumitomo Mitsui Trust Group, Inc. Partly reported under another manager138,030 SH75,063,475 dollarsLower by 64,232 Prior quarter: 202,262Open filing 0001214659-26-013361 Filed 2026-10-29 Dispute this row
Quantinno Capital Management LP 130,540 SH70,990,312 dollarsLower by 52,447 Prior quarter: 182,987Open filing 0001759654-26-000011 Filed 2026-11-13 Dispute this row
BARCLAYS PLC Partly reported under another manager130,088 SH70,744,457 dollarsHigher by 81,847 Prior quarter: 48,241Open filing 0000312069-26-000241 Filed 2026-11-06 Dispute this row
WEDGE CAPITAL MANAGEMENT L L P/NC 128,328 SH69,787,333 dollarsHigher by 22,720 Prior quarter: 105,608Open filing 0001015308-26-000008 Filed 2026-10-13 Dispute this row
Fisher Asset Management, LLC Partly reported under another manager127,159 SH69,151,843 dollarsHigher by 8,229 Prior quarter: 118,930Open filing 0000850529-26-000009 Filed 2026-11-06 Dispute this row
DEUTSCHE BANK AG\ Partly reported under another manager126,193 SH68,626,277 dollarsLower by 7,769 Prior quarter: 133,962Open filing 0000948046-26-000083 Filed 2026-11-06 Dispute this row
GAMCO INVESTORS, INC. ET AL 121,423 SH66,032,256 dollarsLower by 709 Prior quarter: 122,132Open filing 0001140361-26-043449 Filed 2026-11-12 Dispute this row
AustralianSuper Pty Ltd 118,701 SH64,551,978 dollarsLower by 2,361 Prior quarter: 121,062Open filing 0001694164-26-000011 Filed 2026-11-10 Dispute this row
Nuveen, LLC Partly reported under another manager116,174 SH63,177,662 dollarsLower by 13,614 Prior quarter: 129,788Open filing 0000930413-26-003284 Filed 2026-11-10 Dispute this row
CITIGROUP INC Partly reported under another manager108,933 SH59,239,944 dollarsHigher by 64,487 Prior quarter: 44,446Open filing 0000831001-26-000052 Filed 2026-11-04 Dispute this row
Robeco Institutional Asset Management B.V. Partly reported under another manager108,203 SH58,842,955 dollarsHigher by 55,852 Prior quarter: 52,351Open filing 0001418773-26-000004 Filed 2026-10-20 Dispute this row
RHUMBLINE ADVISERS 108,018 SH58,742,286 dollarsLower by 1,485 Prior quarter: 109,503Open filing 0001115418-26-000015 Filed 2026-11-10 Dispute this row
Swiss National Bank 101,040 SH54,947,573 dollarsLower by 3,080 Prior quarter: 104,120Open filing 0001582202-26-000008 Filed 2026-11-12 Dispute this row
Fayez Sarofim Co Partly reported under another manager100,365 SH54,580,494 dollarsLower by 7,632 Prior quarter: 107,997Open filing 0001193125-26-455938 Filed 2026-11-12 Dispute this row
TD ASSET MANAGEMENT INC 92,024 SH49,127,012 dollarsLower by 461,354 Prior quarter: 553,378Open filing 0001193125-26-460060 Filed 2026-11-13 Dispute this row
Rockefeller Capital Management L.P. Partly reported under another manager91,878 SH49,965,339 dollarsHigher by 82,885 Prior quarter: 8,993Open filing 0001739439-26-000009 Filed 2026-11-13 Dispute this row
RAYMOND JAMES FINANCIAL INC Partly reported under another manager91,280 SH49,639,995 dollarsHigher by 14,770 Prior quarter: 76,510Open filing 0000720005-26-000081 Filed 2026-11-12 Dispute this row
GABELLI FUNDS LLC 90,171 SH49,036,793 dollarsLower by 3,838 Prior quarter: 94,009Open filing 0001140361-26-043450 Filed 2026-11-12 Dispute this row
BNP PARIBAS FINANCIAL MARKETS Partly reported under another manager88,040 SH47,877,913 dollarsHigher by 57,212 Prior quarter: 30,828Open filing 0001166588-26-000012 Filed 2026-11-12 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • AQR CAPITAL MANAGEMENT LLC 545,314 SH
  • NORGES BANK 506,330 SH
  • Sixth Street Partners Management Company, L.P. 349,007 SH
  • CHARLES SCHWAB INVESTMENT MANAGEMENT INC 349,007 SH
  • NORTHERN TRUST CORP 330,317 SH
  • GOLDMAN SACHS GROUP INC 257,018 SH
  • Driehaus Capital Management LLC 229,123 SH
  • ALLIANCEBERNSTEIN L.P. 209,694 SH
  • PRICE T ROWE ASSOCIATES INC /MD/ 205,291 SH
  • UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 177,023 SH
  • BANK OF AMERICA CORP /DE/ 163,744 SH
  • AMERIPRISE FINANCIAL INC 151,760 SH
  • ENVESTNET ASSET MANAGEMENT INC 148,589 SH
  • Legal General Group Plc 136,358 SH
  • SCHRODER INVESTMENT MANAGEMENT GROUP 126,758 SH
  • Clark Capital Management Group, Inc. 113,041 SH
  • Zurich Insurance Group Ltd/FI 104,480 SH
  • LAZARD ASSET MANAGEMENT LLC 87,526 SH
  • BROWN ADVISORY INC 85,524 SH
  • SILVERCREST ASSET MANAGEMENT GROUP LLC 81,513 SH
  • WELLS FARGO COMPANY/MN 80,154 SH
  • Gotham Asset Management, LLC 78,769 SH
  • Hardman Johnston Global Advisors LLC 76,411 SH
  • NATIONAL BANK OF CANADA /FI/ 75,326 SH
  • California Public Employees Retirement System 75,125 SH
  • Vident Advisory, LLC 69,806 SH
  • WELLINGTON MANAGEMENT GROUP LLP 52,950 SH
  • ROYAL BANK OF CANADA 47,518 SH
  • Curi Capital, LLC 46,614 SH
  • Caisse de depot et placement du Quebec 46,178 SH
  • Wealth High Governance Asset Management Ltda. 43,434 SH
  • HWG Holdings LP 43,104 SH
  • NEW YORK STATE COMMON RETIREMENT FUND 42,801 SH
  • Visualize Group LP 40,816 SH
  • SCOPUS ASSET MANAGEMENT, L.P. 40,000 SH
  • CANADA PENSION PLAN INVESTMENT BOARD 39,763 SH
  • SCOPUS ASSET MANAGEMENT, L.P. 35,000 SH
  • Allianz Asset Management GmbH 34,078 SH
  • SCOPUS ASSET MANAGEMENT, L.P. 33,642 SH
  • MILLENNIUM MANAGEMENT LLC 32,456 SH
  • STATE OF WISCONSIN INVESTMENT BOARD 30,148 SH
  • NOMURA ASSET MANAGEMENT INTERNATIONAL INC. 29,066 SH
  • AGF MANAGEMENT LTD 26,731 SH
  • Corient Private Wealth LP 25,738 SH
  • ArrowMark Colorado Holdings LLC 25,198 SH
  • TUDOR INVESTMENT CORP ET AL 24,247 SH
  • Hood River Capital Management LLC 23,239 SH
  • FRONTIER CAPITAL MANAGEMENT CO LLC 22,225 SH
  • HSBC HOLDINGS PLC 21,651 SH
  • CITADEL ADVISORS LLC 21,297 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Vanguard Capital Management Common Stock5.211,923,45303/31/2026 Filed 2026-04-29SCHEDULE 13GOpen filing 0002100119-26-000443 Dispute this row
The Vanguard Group Common Stock0003/13/2026 Filed 2026-03-26SCHEDULE 13G/AAmendment 12Open filing 0000102909-26-001101 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,028,787 filings read, dated 2004-06-14 to 2026-11-13: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
20151
2016204,322
2017202,494
2018202,048
2019193,638
2020144,184
2021224,474
202240,015
2023199,811
2024122,476
2025235,520
2026254,026

Filings made before the SEC required XML are listed, not extracted.

Back to CURTISS-WRIGHT CORPORATION